{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Greer JA"],"funding":["American Cancer Society","NIDA NIH HHS"],"pagination":["1111-1120"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6693695"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["24(8)"],"pubmed_abstract":["BACKGROUND:The aim of this study was to test the efficacy of a tailored cognitive-behavioral therapy (CBT) mobile application (app) to treat anxiety in patients with incurable cancer. MATERIALS AND METHODS:Patients with incurable cancers (n = 145) who reported elevated anxiety symptoms at two cancer centers were randomized to receive either the CBT mobile app for anxiety or a mobile health education program (control) delivered via tablet computers, which patients self-administered over 12 weeks. To assess anxiety, depression symptoms, and quality of life (QOL), we used the Hamilton Anxiety Rating Scale (HAM-A, primary outcome), Clinical Global Impression Scale, Hospital Anxiety and Depression Scale (HADS), Patient Health Questionnaire-9, and Functional Assessment of Cancer Therapy-General "],"journal":["The oncologist"],"pubmed_title":["Randomized Trial of a Tailored Cognitive-Behavioral Therapy Mobile Application for Anxiety in Patients with Incurable Cancer."],"pmcid":["PMC6693695"],"funding_grant_id":["124138-RSG-13-019-01-CPPB","K24 DA040489"],"pubmed_authors":["El-Jawahri A","Greer JA","Pirl WF","Safren SA","Fuh CX","Perez GK","Jacobs J","Tallen C","Traeger L","Pensak N","Penedo FJ","MacDonald JJ","Ward A","Muzikansky A","Temel JS"],"additional_accession":[]},"is_claimable":false,"name":"Randomized Trial of a Tailored Cognitive-Behavioral Therapy Mobile Application for Anxiety in Patients with Incurable Cancer.","description":"BACKGROUND:The aim of this study was to test the efficacy of a tailored cognitive-behavioral therapy (CBT) mobile application (app) to treat anxiety in patients with incurable cancer. MATERIALS AND METHODS:Patients with incurable cancers (n = 145) who reported elevated anxiety symptoms at two cancer centers were randomized to receive either the CBT mobile app for anxiety or a mobile health education program (control) delivered via tablet computers, which patients self-administered over 12 weeks. To assess anxiety, depression symptoms, and quality of life (QOL), we used the Hamilton Anxiety Rating Scale (HAM-A, primary outcome), Clinical Global Impression Scale, Hospital Anxiety and Depression Scale (HADS), Patient Health Questionnaire-9, and Functional Assessment of Cancer Therapy-General ","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Aug","modification":"2025-05-31T23:14:19.994Z","creation":"2025-05-31T23:14:19.994Z"},"accession":"S-EPMC6693695","cross_references":{"pubmed":["30683710"],"doi":["10.1634/theoncologist.2018-0536"]}}